XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Unaudited Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Series D
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020     76,494,000 24,696,000      
Beginning balance at Dec. 31, 2020 $ (138,902)   $ 182,599 $ 1 $ 13,233 $ 0 $ (152,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Series D preferred stock (in shares)   2,256,000          
Issuance of Series D preferred stock   $ 13,721          
Issuance of Series D preferred stock - related party   2,466,000          
Issuance of Series D preferred stock - related party   $ 15,000          
Issuance Costs - Series D   $ (1,290)          
Issuance of restricted stock awards - related party (in shares)       6,917,000      
Issuance of restricted stock awards - related party $ 40,237     $ 1 40,236    
Issuance of Common Stock upon exercise of options (in shares) 12,796,353     619,000      
Issuance of Common Stock upon exercise of options $ 864     $ 1 863    
Stock-based compensation expense - options 5,283       5,283    
Other comprehensive gain/loss 0            
Net loss (65,171)           (65,171)
Ending balance (in shares) at Mar. 31, 2021     81,216,000 32,232,000      
Ending balance at Mar. 31, 2021 (157,689)   $ 210,030 $ 3 59,615 0 (217,307)
Beginning balance (in shares) at Dec. 31, 2020     76,494,000 24,696,000      
Beginning balance at Dec. 31, 2020 $ (138,902)   $ 182,599 $ 1 13,233 0 (152,136)
Ending balance (in shares) at Dec. 31, 2021 162,105,399   0 162,105,000      
Ending balance at Dec. 31, 2021 $ 282,136   $ 0 $ 16 710,638 213 (428,731)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Common Stock upon exercise of options (in shares) 139,423     139,000      
Issuance of Common Stock upon exercise of options $ 144       144    
Stock-based compensation expense - options 16,485       16,485    
Other comprehensive gain/loss 88         88  
Net loss $ (48,149)           (48,149)
Ending balance (in shares) at Mar. 31, 2022 162,244,822   0 162,244,000      
Ending balance at Mar. 31, 2022 $ 250,704   $ 0 $ 16 $ 727,267 $ 301 $ (476,880)